首页 | 本学科首页   官方微博 | 高级检索  
     


Exhaled breath condensate: Determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review
Authors:Petr Kubá  ň,Franti&scaron  ek ForetAuthor Vitae
Affiliation:Bioanalytical Instrumentation, CEITEC - Central European Institute of Technology, Masaryk University, Veveri 97, 602 00 Brno, Czech Republic
Abstract:Exhaled breath condensate is a promising, non-invasive, diagnostic sample obtained by condensation of exhaled breath. Starting from a historical perspective of early attempts of breath testing towards the contemporary state-of-the-art breath analysis, this review article focuses mainly on the progress in determination of non-volatile compounds in exhaled breath condensate. The mechanisms by which the aerosols/droplets of non-volatile compounds are formed in the airways are discussed with methodological consequences for sampling. Dilution of respiratory droplets is a major problem for correct clinical interpretation of the measured data and there is an urgent need for standardization of EBC. This applies also for collection instrumentation and therefore various commercial and in-house built devices are described and compared with regard to their design, function and collection parameters. The analytical techniques and methods for determination of non-volatile compounds as potential markers of oxidative stress and lung inflammation are scrutinized with an emphasis on method suitability, sensitivity and appropriateness. The relevance of clinical findings for each group of possible non-volatile markers of selected pulmonary diseases and methodological recommendations with emphasis on interdisciplinary collaboration that is essential for future development into a fully validated clinical diagnostic tool are given.
Keywords:3-NT, 3-nitrotyrosine   5-HPETE, 5-hydroperoxyeicosatetraenoic acid   5-LO, 5-lipoxygenase   8-IP, 8-isoprostane   ALF, airway lining fluid   BAL, bronchoalveolar lavage   CF, cystic fibrosis   COPD, chronic obstructive pulmonary disease   COX, cyclooxygenase   EBC, exhaled breath condensate   FDA, U.S. Food and Drug Administration   GSH, glutathione   GSSG, glutathione disulfide   INF-γ, interferon γ   LT, leukotriene   NMR, nuclear magentic resonance   PCA, principal component analysis   PLS, partial least squares   PLS-DA, partial least squares discriminant analysis   PP, polypropylene   PE, polyethylene   PG, prostaglandin   PTFE, polytetrafluoroethylene   ROS, reactive oxygen species   RS&ndash  NO, S-nitrosothiols   SI, sputum induction   VOC, volatile organic compounds   TNF-α, tumor necrosis factor α
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号